IVOSX | VEVYX | IVOSX / VEVYX | |
Total Expense Ratio | 0.73 | 0.66 | 111% |
Annual Report Gross Expense Ratio | 0.93 | 0.66 | 141% |
Fund Existence | 11 years | 12 years | - |
Gain YTD | 4.455 | -1.320 | -338% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 921M | 17.3B | 5% |
Annual Yield % from dividends | 1.76 | 1.12 | 157% |
Returns for 1 year | -0.70 | -5.40 | 13% |
Returns for 3 years | 20.33 | 5.87 | 346% |
Returns for 5 years | 50.14 | 42.30 | 119% |
Returns for 10 years | 94.30 | 43.83 | 215% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SDP | 14.25 | 0.18 | +1.28% |
ProShares UltraShort Utilities | |||
FRA | 12.92 | 0.01 | +0.11% |
Blackrock Floating Rate Income Strategies Fund | |||
FIAX | 18.26 | -0.01 | -0.05% |
Nicholas Fixed Income Alternative ETF | |||
NULV | 40.71 | -0.46 | -1.12% |
Nuveen ESG Large-Cap Value ETF | |||
BIB | 47.37 | -0.62 | -1.29% |
ProShares Ultra Nasdaq Biotechnology |